【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Burden of Disease
06.3 Etiology
06.4 Pathophysiology
06.4.1 Myocardial Dysfunction
06.4.2 MI
06.4.3 Electrical Dysfunction
06.5 Prognosis
06.6 Epidemiology
06.6.1 Prevalence of Coronary Artery Disease
06.7 Diagnosis
06.7.1 ECG
06.7.2 Blood Tests
06.7.3 Nuclear Scan
06.7.4 CT
06.8 Management
07.ACS Pipeline Landscape
07.1 Key Pipeline Molecules
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by ECG Output
10 Geographical Segmentation
11 Buying Criteria
12 Market Growth Drivers
13 Drivers and their Impact
14 Market Challenges
15 Impact of Drivers and Challenges
16 Market Trends
17 Trends and their Impact
18 Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 AstraZeneca
18.2.2 Bristol-Myers Squibb
18.2.3 Eli Lilly
18.2.4 GlaxoSmithKline
18.2.5 Sanofi
18.3 Other Prominent Vendors
19 Key Vendor Analysis
19.1 AstraZeneca
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2013
19.1.4 Business Segmentation by Revenue 2011-2013
19.1.5 Revenue by Geography
19.1.6 Business Strategy
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.2 Bristol-Myers Squibb
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Product Offerings
19.2.4 Revenue by Geography
19.2.5 Business Strategy
19.2.6 Key Information
19.2.7 SWOT Analysis
19.3 Eli Lilly
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue
19.3.4 Revenue by Geography
19.3.5 Business Strategy
19.3.6 Key Information
19.3.7 SWOT Analysis
19.4 GlaxoSmithKline
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Revenue by Geography
19.4.6 Pipeline Products
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.5 Sanofi
19.5.1 Key Facts
19.5.2 Business Description
19.5.3 Business Segmentation
19.5.4 Revenue by Business Segmentation
19.5.5 Revenue Comparison 2012 and 2013
19.5.6 Revenue by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis
20 Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Spectrum of ACS
Exhibit 3: Overview of ACS
Exhibit 4: Pathogenesis of ACS
Exhibit 5: Hospitalized Incident Cases of ACS 2014-2019 (millions)
Exhibit 6: Epidemiologic Transition of CV Diseases
Exhibit 7: Initial Drug Therapy for ACS
Exhibit 8: Adjunctive Drug Therapy for ACS
Exhibit 9: Surgery and Other Procedures
Exhibit 10: Snapshot of Global ACS Market 2014
Exhibit 11: Global ACS Market 2014-2019 (US$ billion)
Exhibit 12: Global ACS Market Share of Branded and Generic Drugs 2014 and 2019 (in Percent)
Exhibit 13: Segmentation of Global ACS Market by ECG Output
Exhibit 14: Diagrammatic Representation of STEMI, NSTEMI, and UA
Exhibit 15: Segmentation of Global ACS Market by ECG Output 2014
Exhibit 16: Global ACS Market by Geography 2014
Exhibit 17: Drivers of Global ACS Market
Exhibit 18: Comparison of Elderly Population 2012 and 2050 (Aged 65 and Older)
Exhibit 19: Challenges in Global ACS Market
Exhibit 20: Trends in Global ACS Market
Exhibit 21: Global Revenue of AstraZeneca for CV and Metabolic Diseases 2011-2013 (US$ million)
Exhibit 22: Estimated Filings of Brilinta/Brilique
Exhibit 23: Line Extensions for Brilinta/Brilique
Exhibit 24: Global Revenue of Brilinta/Brilique by AstraZeneca 2011-2013 (US$ million)
Exhibit 25: Global Revenue of Plavix by Bristol-Myers Squibb 2010-2012 (US$ million)
Exhibit 26: Revenue of Eli Lilly by Therapeutic Area 2013
Exhibit 27: Global Revenue of Effient by Eli Lilly 2010-2013 (US$ million)
Exhibit 28: Global Revenue of Arixtra by GlaxoSmithKline 2011-2013 (US$ million)
Exhibit 29: Global Revenue of Plavix by Sanofi 2011-2013 (US$ million)
Exhibit 30: Global Revenue of Lovenox by Sanofi 2011-2013 (US$ million)
Exhibit 31: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 32: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 33: AstraZeneca: Revenue by Geography 2013
Exhibit 34: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 35: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 36: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 37: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 38: Eli Lilly: Revenue by Geography 2013
Exhibit 39: GlaxoSmithKline: Business Segmentation 2013
Exhibit 40: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 41: GlaxoSmithKline: Revenue by Geography 2013
Exhibit 42: GlaxoSmithKline: Pipeline Products 2013
Exhibit 43: Sanofi: Business Segmentation
Exhibit 44: Sanofi: Revenue by Business Segmentation 2013
Exhibit 45: Sanofi: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 46: Sanofi: Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：急性冠症候群(ACS)治療薬の世界市場2015-2019■ 英文：Global Acute Coronary Syndrome (ACS) Market 2015-2019
■ 発行日：2015年3月18日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5471
■ 調査対象地域：グローバル
- データセンター冷却の世界市場予測（～2021）：ソリューション別（エアコン、チリングユニット、冷却塔、エコノマイザ装置、液体冷却装置、コントロールシステム、その他）、サービス別、冷却種類別、データセンター種類別、産業別、地域別The data center cooling market is estimated to grow from USD 7.12 Billion in 2016 to USD 14.28 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 14.95% during the forecast period. Data center cooling solutions are witnessing an increasing demand due to the various benefits for effective heat removal provided by these solutions. Additionally, data center cooling solutions are becomin …
- BEOL（バックエンド）半導体装置の世界市場：ステッパー、CVD装置、塗布・現像装置、ウェットステーション、PVD装置、CMP装置、金属エッチング装置About Semiconductor Equipment Industry The semiconductor equipment industry is an important part of the overall semiconductor market, with semiconductor chip makers investing 20% of their sales toward obtaining manufacturing equipment. The equipment manufacturing companies are leading the development of most core process technologies in the semiconductor market. The semiconductor production equipm …
- 気道陽圧機器（PAP）の世界市場2016-2020About Positive Airway Pressure Devices Positive airway pressure (PAP) devices are used in intensive care units (ICUs), coronary care units (CCUs), operating rooms, and emergency wards of hospitals. PAP devices are pre-dosed pressure delivery systems that ensure upper airway pressure flow to keep the airways open during the treatment of obstructive sleep apnea (OSA). Congestive heart failure, sleep …
- 光ファイバー・ビームエクスパンダーの世界市場：ケプラー式/ガリレイ式ビームエクスパンダーThe global fiber optic beam expander market is witnessing a very high growth rate, which is due to the increasing need for optical assemblies and components to enhance the efficiency and effectiveness of the laser processing systems as well as the optical communication systems. The fiber optics industry is witnessing an impressive increase in the consumption of the optical elements and components. …
- 織物産業における廃棄物管理の世界市場ABSTRACTAbout Textile Industry Waste Management The textile industry consumes huge quantities of water and produces substantial amounts of wastewater. The textile industry is important for many countries in terms of trade, GDP, and employment rates. The industry provides opportunities to low-income countries for export diversification and expansion of manufactured exports by exploiting their labor …
- 世界のウエハー・レベル・パッケージング装置市場動向（2014～2018）TechNavio's analysts forecast the Global Wafer-level Packaging Equipment market to grow at a CAGR of (2.9) percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing adoption of mobile devices. The Global Wafer-level Packaging Equipment market has also been witnessing the increasing number of innovations by customers. However, the cyclical nature …
- 世界における半導体ドライストリップシステム市場：Global Semiconductor Dry Strip Systems Market 2014-2018TechNavio's analysts forecast the Global Semiconductor Dry Strip Systems market to grow at a CAGR of 0.22 percent over the period 2013-2018. One of the key factors contributing to this market growth is the rising demand for smartphones and tablets. The Global Semiconductor Dry Strip Systems market has also been witnessing the increased collaborations between semiconductor equipment manufacturers. …
- データサイエンスプラットフォームの世界市場予測（～2021年）“Advancement in big data technologies is one of the drivers for the growth of the data science platform analytics market”The data science platform market size is estimated to grow from USD 19.58 billion in 2016 to USD 101.37 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 38.9%. Enterprises are focusing on methods enabling simpler use of data to drive their business and advancement in …
- 癌・腫瘍プロファイリングの世界市場予測（～2021）：用途別、手法別（ゲノミクス、 プロテオミクス、メタボロミクス、エピジェネティックス）、技術別（次世代シーケンシング、qPCR、in-situハイブリダイゼーション、マイクロアレイ）The global cancer/tumor profiling market is projected to reach USD 61.87 Billion by 2021 from USD 25.82 Billion in 2016, growing at a CAGR of 19.1% during the forecast period. Growth in the cancer profiling market is driven by the increasing number of cancer cases, growing utility of biomarker in tumor profiling, and availability of funding for cancer research. In addition, the introduction and ad …
- フリップチップの世界市場2018-2022About Flip Chip Flip chip is a type of packaging type, which interconnects chip and package carriers or substrates using a conductive bump. Conductive bumps are placed on the die surface, which is flipped to connect the substrate directly. Technavio’s analysts forecast the Global Flip Chip Market Market to grow at a CAGR of 6.22% during the period 2018-2022. Covered in this report The report cover …
- コンパニオン診断の世界市場：免疫組織化学、ポリメラーゼ連鎖反応[PCR]、次世代シーケンシング[NGS]、in situハイブリダイゼーションThe global companion diagnostics market generated $1,678 million in 2018, and is projected to reach $6,452 million by 2026, growing at a CAGR of 18.3% from 2019 to 2026. Companion diagnostic is a medical device, often an in-vitro device that provides information essential for the safe and effective use of a corresponding drug or biological product. These tests help a health care professional to de …
- 石油スルホネートバリウムの世界市場2015Barium Petroleum Sulfonate (CAS 61790-48-5) Market Research Report 2015 aims at providing comprehensive data on Barium Petroleum Sulfonate market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Barium Petroleum Sulfonate description, covers its application areas, manufacturing methods, patterns. It captures Barium Petroleum Sulfonate market trends, pay …
- 活性アルミナの世界市場2016-2020About Activated Alumina Activated alumina is a highly porous material produced by the dehydroxylation of aluminum hydroxide. The compound has a high surface-to-weight ratio with a surface area between 120 and 250 square meters per gram of the raw material. It does not soften or disintegrate when immersed in liquids. Activated alumina is good packing media and is used as an air and gas desiccant, d …
- ナノセンサー市場動向2014Nanosensors -- devices capable of detecting nanoparticles -- are already in use in the medical diagnosis field, but are expected to see near-term commercialization in military, domestic security and environmental monitoring applications, as well as several other areas. NanoMarkets believes that longer-term revenue generation from nanosensors will also emerge from a variety of uses for such sensors …
- 自動車用温度センサ及び湿度センサの世界市場：MEMS技術、CMOS技術、薄膜ポリマー技術A combination of sensing element, analog to digital converter, analog interface, and a bus interface circuit in one housing is known as smart sensor. The circuitry for digital sensors is similar to the on described above, therefore all digital sensors have been considered as smart sensors for this market study. This report focuses on an in-depth segmentation of the smart relative humidity & temper …
